These differential drug sensitivity results are also consistent with previous bulk studies on invasive phenotypes of melanoma: MITF-low, invasive (or mesenchymal) melanoma cells have been reported to be more dependent on NFκB signaling10, and the single-cell resolution of our study reveals the exact molecular and cellular dynamics behind that observation. Here, NFKB1 is linked to melanoma.